K Pharma,Inc.
JPX: 4896.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Komei Fukushima
- Employees
- 17
- Headquarters
- Minato-ku, Japan
- IPO year
- 2023
- Market cap
- ¥8.7B
- Website
- https://www.kpharma.co.jp
Loading 4896…
Loading profile data…Frequently asked questions about 4896
What does K Pharma,Inc. (4896.T) do?
K Pharma,Inc. engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan. It develops regenerative medicine products using disease-specific induced pluripotent stem (iPS) cell technology for spinal cord injuries and cerebral infarctions. The company was incorporated in 2016 and is b...
Where does 4896.T trade?
K Pharma,Inc. (4896.T) trades on the Tokyo Stock Exchange.
What sector is 4896.T in?
K Pharma,Inc. (4896.T) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of K Pharma,Inc.?
Komei Fukushima is the chief executive officer of K Pharma,Inc. (4896.T).
Where is K Pharma,Inc. headquartered?
K Pharma,Inc. is headquartered in Japan.
Does 4896.T pay a dividend?
K Pharma,Inc. (4896.T) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4896.T go public?
K Pharma,Inc. (4896.T) completed its initial public offering in 2023.